Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Minnesota Releases PTSD Report

At over 200 pages, this comprehensive report includes a review of PTSD claims in the workers’ comp system.
Read More →
August 11, 2025

Pennsylvania Proposes Cannabis Reimbursement Bill

If enacted, insurers would be required to reimburse up to $250 per month for qualified medical use.
Read More →
August 11, 2025

Senate Introduces Federal Heat Standard Bill

If enacted, OSHA would be required to adopt a federal standard for enforceable protections.
Read More →
August 11, 2025

South Dakota Approves Rulemaking for Physician Fee Schedule

The 2025 Optum RVPs for medical services and treatments will be adopted, but with current conversion factors.
Read More →
August 11, 2025

NCCI Reports on Medical Inflation Highlights

While overall medical inflation remains low, certain tariffs are still pending, which could impact long-term costs.
Read More →
August 4, 2025

California Publishes 2025 State of the System Report

Medical costs went up 8% in 2024, driven by increased utilization, fee schedule inflation, and growth in medical-legal services.
Read More →
August 4, 2025

California Sees Delay to Utilization Review Regulations

The Office of Administrative Law informed the DWC that seven areas of the proposed update required additional clarification or public notice.
Read More →
August 4, 2025

NCCI Publishes Labor Market Insights

147,000 new jobs were reported in June, though half were driven by likely-seasonal education jobs.
Read More →
July 28, 2025

NCCI Publishes Industry Trends Report

While claim severity decreased across all industries, construction saw the steepest decline since 2015.
Read More →
July 28, 2025
1 … 32 33 34 35 36 … 62

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.
Read More

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.
Read More

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.
Read More

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Read More

New York Prepares to Launch New Claim Portal

Stakeholders will soon experience a streamlined digital process for managing claims.
Read More

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Read More
1 … 32 33 34 35 36 … 53
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle